Literature DB >> 20574152

Molecular therapy for melanoma: useful and not useful targets.

Christopher Abdullah1, Xiaolei Wang, Dorothea Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20574152     DOI： 10.4161/cbt.10.2.12595

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  1 in total

1.  A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma.

Authors:  Rui-Qing Peng; Ya Ding; Xing Zhang; Yuan Liao; Li-Min Zheng; Xiao-Shi Zhang
Journal:  Cancer Biol Ther       Date:  2012-09-06       Impact factor: 4.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.